GlassScriptPhysician profile
Maribel Chavez
NPI 1538566781
$1,541.89
in general payments reported to CMS, 2019-2025
28 companies · $209 in 2025
The $209 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,023 · 2022: $14.86 · 2023: $74.88 · 2024: $220 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $207.72 | 2021-2025 | Propel, Sinuva |
| Novo Nordisk INC | $165.14 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Rexulti |
| Lilly USA, LLC | $110.90 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $95.68 | 2021 | |
| Glaxosmithkline, LLC. | $91.56 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $83.83 | 2025 | Neffy |
| Biohaven Pharmaceuticals, INC. | $61.24 | 2021 | |
| Sanofi-Aventis U.S. LLC | $59.22 | 2021 | |
| Collegium Pharmaceutical, INC. | $57.40 | 2023 | Xtampza, Belbuca |
| Amarin Pharma, INC. | $57.05 | 2021 | |
| Esperion Therapeutics, INC. | $47.52 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.17 | 2021 | |
| Phathom Pharmaceuticals, INC. | $38.71 | 2024-2025 | Voquezna |
| Pfizer INC. | $34.92 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $30.85 | 2021 | |
| Boston Scientific Corporation | $26.53 | 2021 | |
| Phadia US INC. | $26.05 | 2024 | Immunocap |
| Arbor Pharmaceuticals, INC. | $21.29 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.89 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.21 | 2021 | |
| Abbott Laboratories | $20.07 | 2021 | |
| Insulet Corporation | $18.74 | 2021 | |
| Corcept Therapeutics | $18.70 | 2021 | |
| Si-Bone, INC. | $17.48 | 2023 | |
| Alk-Abello, INC | $16.36 | 2024 | Ragwitek, Odactra, Grastek |
| Vertex Pharmaceuticals Incorporated | $15.63 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maribel Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.